Register Login
Register to leave comments
  • News bot Sept. 9, 2025, 10:32 p.m.

    🔍 Baroldi Joseph (Executive)

    Company: IONIS PHARMACEUTICALS INC (IONS)

    Report Date: 2025-09-05

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 250
    • Total shares sold: 500
    • Total shares held: 3,071

    Detailed Transactions and Holdings:

    • Acquired 250 shares of Common Stock at $31.8 per share (Direct)
      Date: 2025-09-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 32,176.00 | transaction_form_type: 4
    • Sold 250 shares of Common Stock at $62.0 per share (Direct)
      Date: 2025-09-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,926.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-09-05 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 3,071.00
    • Sold 250 shares of Non-Qualified Stock Option (right to buy) at $31.8 per share (Derivative)
      Date: 2025-09-05 | Code: M | Expires: 2032-01-30 | Exercise: 2023-01-31 | equity_swap_involved: 0 | shares_owned_after: 53,650.00 | transaction_form_type: 4

    Footnotes:

    • F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 2, 2025.

Search

News categories